Introduction
Lithocholic acid is a secondary bile acid, formed in the colon by the bacterial 7a-dehydroxylation of chenodeoxycholic acid (1) . Small amounts of lithocholic acid are reabsorbed from the colon, cleared from the portal blood by the liver, and metabolized. Hepatic metabolism results in the formation of taurine and glycine conjugates linked by amide bonds with the steroid carboxylic acid, or in the formation of 3-sulfate esters, or in combined sulfated conjugates (2) .
More recently it has been shown that the glucuronide conjugate of lithocholic acid is present in quantity in the serum and urine of patients with cholestatic liver disease (3) (4) (5) (6) . The conjugate is the 3-0-f3-D-glucuronide of lithocholic acid' 2 (LCG) (Fig. 1) . The accumulation of LCG in blood in such patients suggests that it may normally be secreted in bile, but that it accumulates in blood when hepatic secretion fails. Surprisingly little, however, has been established about the normal metabolic fate of the substance. Accordingly, we have prepared radiolabeled LCG and administered it to rats prepared with a biliary fistula. The results show that when microgram quantities ofthe material are injected intravenously into rats, the material is secreted in bile largely I. Abbreviations used in this paper: DEAP, diethylaminohydroxypropyl; FAB-MS, fast atom bombardment-mass spectrometry; GC, gas chromatography; LCG, 3-O-0-D-glucuronide of lithocholic acid; HPLC, highpressure liquid chromatography; Rf, retardation factor; Rt, retention time; Rv, retention volume.
2. For the purpose of this paper, the free acid and salt forms of the glucuronide will be considered equivalent and will henceforth be referred to by the abbreviation LCG. intact. When larger quantities are administered, cholestasis results, additional metabolites are formed, and radiolabel accumulates in tissues.
Methods Experimental design. (3H]LCG was administered intravenously to rats
prepared with an external biliary fistula. The amounts administered varied from microgram to milligram amounts, and the mode of administration was by bolus injection or constant infusion. Radiolabel in bile, urine, plasma, viscera, and carcass was determined. The nature of the radiolabeled material secreted in bile was determined chromatographically, before and after specific enzymatic hydrolysis, and by fast atom bombardment-mass spectrometry (FAB-MS).
Synthesis of lithocholate glucuronide. Methyl lithocholate (Cal- biochem-Behring, La Jolla, CA) was oxidized with Jones reagent to the 3-oxo derivative. Subsequent reduction with NaB3H4 (New England Nuclear, Boston densed with methyl 2,3,4-tri-0-acetyl-l-bromo-l-deoxy-a-D-lucopyranuronate in benzene using silver carbonate as catalyst and molecular sieve (3A) as dessicant (7) . The reaction mixture was treated with 0.05 N sulfuric acid in acetone (15 min) to decompose the ortho ester side product and was subjected to deprotection in 1 N NaOH in 72% ethanol, room temperature, for 48 h. The product was acidified with 10% HCI, passed through an XAD-2 (Aldrich Chemical Co., Milwaukee, WI) column (1 X 20cm) and eluted with 2% ammonia in methanol. The eluate, containing the ammonium salt ofthe LCG, was pased over an Amberlyst A-15 (Aldrich Chemical Co.) column (1 X 12 cm) with the effluent flowing directly onto a column (0.75 X 12 cm) of diethylaminohydroxypropyl (DEAP)-Sephadex LH-20 (prepared as described in [8] ).
The latter column was washed with 70% methanol to remove neutral compounds, and the glucuronide was separated from unreacted lithocholic acid by stepwise elutions with acetic acid-ammonia buffer solutions (8) . Lithocholic acid was eluted first with 0.1 M acetic acid buffer, pH 3.8, after which the glucuronide was recovered from the column with 0.3 M acetic acid-ammonia buffer, pH 5. Eluate fractions were treated with two drops of 10% ammonia in methanol and the residue was subjected to lyophilization to remove all traces ofammonium acetate.
The resultant [3H]LCG diammonium salt was 97% radiochemically pure, as demonstrated by TLC in two solvent systems described below. The product of the analogous reaction using unlabeled methyl lithocholate and the bromosugar was subjected to column chromatography on silica gel using benzene-ethyl acetate (1:1) as eluent. The protected LCG was eluted immediately after the ortho ester side product and, on recrystallization from ethanol, formed colorless needles, 180-1820C melting point. The crystalline material was deprotected as above. The solution was evaporated to dryness and the disodium salt of LCG was recrystallized from 72% aqueous ethanol, forming crystalline plates that decomposed above 260'C. FAB-MS spectra were obtained as described elsewhere. The disodium salt ofLCG was characterized by its 'H-nuclear magnetic resonance spectrum in D20 at room temperature. In addition to the expected signals for the steroid moiety between 0.8 and 2.2 ppm, the spectrum exhibited signals for five protons in the region 3.2-4.8 ppm due to the glucuronide residue. The H-l' signal appeared as a doublet (J = 8 Hz) centered at 4.6 ppm, which is characteristic for a P-D-glucopyranuronide.
Surgical preparations. 200-600-g adult male Sprague-Dawley rats were anesthetized with ether. The right or left femoral triangle was incised and a polyethylene catheter (0.58 mm id., 0.965 mm o.d.; ClayAdams, Parsippany, NJ) was inserted in the femoral vein. Thereafter, a constant infusion of 5% dextrose in 0.2% sodium chloride solution was maintained at the rate of 15-20 ml, 100 g'l body weight, day-' for the duration ofthe experiment, except when changed by the experimental protocol. The femoral incision was closed, and a midline abdominal incision provided entry to the peritoneal cavity. The common bile duct was isolated and ligated just proximal to the entry of the pancreatic ducts. A polyethylene catheter (0.28 mm id., 0.61 mm o.d.) was then inserted in the common bile duct proximal to the ligature. The biliary catheter was externalized through an abdominal stab wound and the abdominal incision was closed. The rat was placed in a Bollman restraining cage and was allowed 3 h for recovery from the effects of anesthesia and surgery before we proceeded with the experiment. Body temperature was monitored and maintained at 370-380C.
Experimental protocol Three groups of rats were studied (Table I) The third group (rats 9-12) received successive 1-h infusions of normal saline, normal saline plus sodium taurocholate delivered at 0.05 umol, 100 g'l body weight, minute', and normal saline, taurocholate (rate of delivery as before), and [3H]LCG, the latter delivered for 1 h each at rates of 0.05, 0.10, 0.15 pmol, 100 g'l body weight, minute'. For the sixth 1-h period saline and taurocholate were infused, and, thereafter, until 20 h, the time of sacrifice, rats were infused with 5% dextrose in 0.2% saline.
Bile was collected in preweighed tubes and bile volumes were determined gravimetrically. Urine was collected as a single sample for the entire experimental period. Blood was collected at the time of sacrifice from the abdominal aorta, and plasma was separated and frozen. In one rat, blood samples were obtained every 15 min during the equimolar infusion of taurocholate and [3HJLCG (0.05 ,mol, 100 g-' body weight, minute-'). Liver, intestine, and kidneys from all animals were removed and frozen for later analysis. Lung, heart, brain, skin, and muscle were removed and analyzed as noted in Table I. Analytical techniques. For measurement of radiolabel in biological tissues, samples were homogenized in 5-20 ml ofdistilled water. Aliquots of the homogenates were suspended in a mixture of 95% ethanol-ammonia (1000:1 v/v), heated at 750-80'C for 30 min, and then centrifuged at 1,000 g for 10 min. The total weights of skin and muscle mass per rat were calculated as 18.0 and 45.4% of total body weight, respectively (9) . Aliquots of bile, urine, plasma, and ethanol extract of tissue homogenates were analyzed for radiolabel in ACS scintillant (Amersham Corp., Arlington Heights, IL) in a Tracor Mark III, model 6882, liquid scintillation system (Tracor Analytic Inc., Elk Grove Village, IL).
Bile samples were analyzed chromatographically on Whatman LK-5 thin-layer plates (Pierce Chemical Co., Rockford, IL). Isooctaneethyl acetate-glacial acetic acid (50:50:2.5) (solvent system I) and chloroform-methanol-glacial acetic acid-water (65:25:2:4) (solvent system II) were employed for the chromatography of free and conjugated bile acids, respectively. Plates were developed to 19 cm from the origin and dried. Standards of free and conjugated bile acids (Calbiochem-Behring) were visualized by spraying with 3.5% phosphomolybdic acid in isopropanol and heating at 1 10C for 20 min. Samples lanes were divided into 1-cm segments from the origin to the front, and the gel in each segment was transferred to a scintillation vial. The gel was mixed with I ml of methanol for 30 min before counting the mixture in ACS scintillant fluid.
To prepare bile samples for high-pressure liquid chromatography (HPLC) and gas chromatography (GC), aliquots were acidified and extracted with diethyl ether (80-90% of the label in bile was recovered in the ether phase). The ether extracts, containing the [3H]LCG, were divided in half and dried. One portion was used without further manipulation for HPLC analysis and the second was converted to the methyl ester acetate derivative (10) before GC analysis.
HPLC analysis was performed with a Waters Associates, Millipore Corp. (Milford, MA) HPLC equipped with a gradient elution system and a model 450 variable wavelength ultraviolet detector set at 196 nm.
An LC-18 column (Supelco Inc.) (5 tg particle size; 4.6 mm ID, 15-cm length) was used with a mobile phase composed of 2 mM phosphate buffer, pH 7.0 (prepared by adjusting 2 mM phosphoric acid to pH 7.0 with 5 N NaOH) and acetonitrile. Bile extracts and steroids were dissolved in the phosphate buffer and 10-20-Mil aliquots were injected onto the column. Chromatography was carried out at a flow rate of 1 ml/min with gradient elution from 0 to 40%6 acetonitrile in 2 min followed by isocratic elution at 40% acetonitrile for 20 min. Fractions (1 ml each) were collected throughout the chromatograph and these were subsequently counted to correlate elution of mass (detected by ultraviolet absorption at 196 nm) and label.
The methyl ester acetate derivatives ofLCG were analyzed by capillary GC on a H-P 5880-A gas chromatograph (Hewlett-Packard Co., Avondale, PA) equipped with a capillary injector and flame-ionization detector. A short length of DB-1 column (0.25 mm ID, 2.5-m length; J & W Scientific, Rancho Cordova, CA) was used with nitrogen as carrier gas at 1 psi. Samples and standards dissolved in toluene were injected (0.2-1.0 Ml). Chromatography was performed either isothermally at 3000C or under a temperature program from 200-3000C (2000C for 1 min, then increasing to 3000 at 5°C/min). Injector and detector temperatures were 2900 and 300°C, respectively, in both modes of operation.
[3H]LCG in bile samples was prepared for FAB-MS analysis by the following chromatographic procedure. Samples were acidified, applied to an Amberlite XAD-2 column, and eluted with 95% ethanol-0.25% ammonium hydroxide. The eluate was dried, dissolved in aqueous ethanol, applied to an Amerlyst A-15 column (Aldrich Chemical Co.), eluted with 72% aqueous ethanol, and allowed to flow directly onto a DEAP Sephadex LH-20 column. This column was eluted with 0.2 M acetate buffer in a pH gradient, 3.9-9. (Table  I) . 76.9±3.6% (mean±SEM) of the material was secreted in bile within 30 min of injection (Fig. 2) . 89.1±4.5% of the material was eventually recovered in bile over the 20 h before sacrifice.
Smaller amounts of radiolabel were recovered in urine and were subjected to f3-glucuronidase hydrolysis, acidified, and extracted into diethyl ether. 89% of the radiolabel contained in the sample was ether extractable, and, of this fraction, 80.9% of the radiolabel, after TLC in solvent system I (designed to separate unconjugated bile acids), migrated with an Rf (retardation factor) of 0.52, which was identical to that of authentic lithocholic acid. 10.1% of the radiolabel remained at the origin, and there were no other identifiable bands of radiolabel.
Bile samples were then applied directly to TLC plates and developed in solvent system II (designed to separate bile acid conjugates). 81.0% of the radiolabel migrated with an Rf of 0.33, which was identical to that ofauthentic LCG. An additional 14.9% of the radiolabel migrated in a band with an Rf of 0.13. No other discrete bands of radiolabel were observed on the chromatogram. (Fig. 4) . Bile Three additional rats received 3-5 mg [3H]LCG each. Bile was collected for 60 min and the collections were pooled. The samples were subjected to column chromatography on Amberlite XAD-2, Amberlyst A-15, and DEAP Sephadex LH-20 as described above. 60% of the radiolabel was eluted with an Rv identical to that of authentic LCG (at gradient pH -8.5), while an additional 23% was eluted from the column, only under more basic conditions (gradient pH -9.0). The larger fraction was converted to the sodium salt, dried under N2, and subjected to FAB-MS. Pseudomolecular ions of the labeled conjugate under FAB conditions were qualitatively identical to those of an authentic sample of lithocholate-3-O-f3-D-glucuronide disodium salt. Ions were observed at m/e 619, 597, and 575 corresponding to (M + Na)+, (M + H)+, and (M + H -Na)+ respectively.
Lithocholate solubility in aqueous solutions. The aqueous solubilities of lithocholic acid and its conjugates were measured (Table II) . The glucuronide conjugate was -20 times more soluble than the unconjugated parent compound, 50 times more soluble than the amide conjugates, and seven times more soluble than the sulfate conjugate. The solubility of the combined amide- 
Discussion
It is well established that bile acids are conjugated with taurine and glycine through amide bonds at the steroid side-chain carboxyl group (1) . Bile acids also form sulfates, primarily, though not exclusively, through esterification of the 3-hydroxyl group. It is less generally appreciated that glucuronide formation plays a role in bile acid metabolism (3) (4) (5) (6) . Bile acid glucuronyl transferase is a microsomal enzyme with bile acid specificity inversely proportional to the number of hydroxyl groups on the steroid moiety (4). Enzyme activity is induced by the administration in vivo of phenobarbital and is competitively inhibited by bilirubin (4). Microsomal enzyme activity in vitro is increased by certain detergent substances and might be altered by the detergent properties of bile acids themselves.
It is, therefore, not surprising that bile acid glucuronides are demonstrable in vivo. The amounts found in normal individuals are minute, but greater amounts have been shown to be present in the bile, urine, and plasma of patients with cholestasis (3, 5, 6) . Glucuronides of the full range of conventional human bile acids have been identified, as have atypical bile acid glucuronides. As might be predicted from the specificity ofbile acid glucuronyl transferase, glucuronide conjugates of monohydroxylated bile acids are most plentiful, and in some patients may represent 20-30% of the monohydroxylated bile acid fractions in plasma or urine (5) . The relative percentage of bile acid glucuronides increased with phenobarbital treatment of cholestasis (5) .
In the present study we have examined the metabolism and disposition of LCG. Bile acid glucuronide metabolism has not been examined in detail previously. The metabolism of LCG is of especial interest since, as noted above, the percentage conversion of monohydroxylated bile acids is considerable, because LCG accumulates in patients with cholestasis, and because of the known toxicity of lithocholate and certain of its other derivatives.
The results show that microgram doses ofradiolabeled LCG administered intravenously were rapidly secreted in bile, and that three quarters of the labeled material in bile was unaltered LCG. After hydrolysis with f3-glucuronidase, chromatographic behavior was identical to lithocholate. Before hydrolysis, the radiolabel migrated on TLC identically to authentic LCG's migration, and its FAR-MS spectrum contained fragment peaks identical to those of LCG.
When milligram quantities of [3H]LCG were administered, a portion of the dose was secreted in bile as unaltered LCG; but, as time elapsed after administration, an increasing fraction was secreted as more polar radiolabeled metabolites. The increased polarity was indicated by slower migration in a TLC system that promotes rapid migration of less polar substituents. That at least a major fraction of this more polar material was the taurine conjugate ofLCG is strongly suggested by the studies in which the unknown polar conjugate(s) was subjected to hydrolysis with fl-glucuronidase. The chromatogratphic behavior of the hydrolyzed material was identical to that of authentic taurolithocholic acid, and hydrolysis was completely inhibited by inclusion of the fl-glucuronidase inhibitor, saccharolactone, in the incubation medium. Direct chromatographic comparison of the polar metabolite with taurolithocholate glucuronide was not possible, since an authentic standard of the latter was not available. (14, 18, 19) . Most bile acids given in sufficient quantity are capable of producing cholestasis, but the precise mechanism is not fully understood (20) . The characteristics of lithocholate that permit it and certain of its derivatives, at low doses, to produce cholestasis have not been adequately explained. It is readily seen, therefore, that no simple explanation is available for the cholestatic properties of another lithocholic acid derivative, LCG. Nevertheless, the solubility characteristics ofLCG may be relevant. As shown above, LCG is highly water soluble, but it is precipitated by equimolar concentrations of calcium chloride. LCG is partially or completely maintained in calcium-containing solutions if excess taurocholate is added. In view of the relative concentrations of LCG and other bile acids in bile at the time bile became turbid (-2 mM), LCG precipitation would be anticipated.
It remains to be seen whether LCG precipitation per se initiates cholestasis. After a sufficient dose, bile plugs capable of obstructing the polyethylene catheter are present in bile that are most likely composed of calcium salts of LCG. A similar deposition of LCG might obstruct flow at the ductal, ductular, and/or canalicular level. It has also been suggested that lithocholate and its derivatives produce cholestasis by changing the physical and chemical properties of canalicular membrane, or by altering the vesicular transport across the liver cell of substances destined to enter bile (12, 13, 17, 21) . Alternatively, it is tempting to speculate that lithocholate derivatives and, specifically, LCG may bind intracellular calcium and/or change entry of calcium into hepatocytes, thereby altering intracellular calcium concentrations. Were this to occur, changes in a broad spectrum of cellular functions might be anticipated in view of the role of intracellular calcium as a modulator of basic cellular functions (22) . Systematic study oflithocholate and its derivatives might offer an interesting probe with which to dissect the pathogenesis of cholestasis and hepatocellular toxicity.
Finally 
